We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.50 | -0.14% | 1,726.00 | 1,726.00 | 1,727.00 | 1,739.50 | 1,724.50 | 1,733.00 | 1,220,102 | 12:53:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.44 | 71.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
12/6/2017 13:02 | LONDON-- GlaxoSmithKline PLC (GSK.LN) Monday announced positive results for its malaria treatment tafenoquine in Phase III testing. The drug giant said a single dose the treatment, used to prevent relapses of Plasmodium vivax malaria, reduced the risk of relapse in patients significantly more than a placebo when given alongside a 3-day blood-stage chloroquine treatment. | tradermichael | |
12/6/2017 08:21 | Buy those dips Sir! | ny boy | |
11/6/2017 08:07 | Never take for granted what Analysis are paid to print.Take it with a pinch of Salt.GSK wiil go to £20 in time,but my experience suggest it could also retrace to the £15 area like it did in on Jan 30,at 1515p, when I purchased GSK for my son,s ISA. | garycook | |
10/6/2017 18:57 | HSBC Has Just Reaffirmed GBX 1970.00 Target Price Per Share on GlaxoSmithKline PLC (LON:GSK) stock, While They've Also Reiterated Their "Buy" RatingJune 7, 2017 - By Linda RogersGlaxoSmithKlin | mj19 | |
10/6/2017 04:06 | I would Love a top up at £15,to replace the top slice of the 300 I just sold at 1702p. | garycook | |
09/6/2017 08:23 | Nothing to do with softer Sterling then? | ianood | |
09/6/2017 08:12 | Onwards & upwards, investors flight to quality during uncertain times | ny boy | |
09/6/2017 07:53 | Should be an interesting day today post-election. Sterling will drop (good for GSK) but I suspect overall market will fall too. | warrior boy | |
06/6/2017 14:31 | S&P Global downgrading to 'strong sell' tp 1500p .....doing us no harm at all. 👍🏼 | philanderer | |
05/6/2017 16:52 | My very wee short now in the money so moving the stop down as she goes. | toffeeman | |
03/6/2017 15:28 | I see the FT has come out in favour of 'vote Conservative' .....Guardian 'Labour' | philanderer | |
02/6/2017 14:15 | I'm rubbish at trading so I just hold for the long term and good dividend.....unless fundamentals change. | spcecks | |
02/6/2017 12:57 | London, UK 01 June 2017 - GSK and ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced regulatory submissions to the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) for a single-tablet, two-drug regimen of dolutegravir (Tivicay, ViiV Healthcare) and rilpivirine (Edurant, Janssen Sciences Ireland UC) for the maintenance treatment of HIV-1 infection. The submissions are based on the SWORD studies that included more than one thousand patients who previously achieved viral suppression on a three- or four-drug (integrase inhibitor, non-nucleoside reverse transcriptase inhibitor, or protease inhibitor-based) antiretroviral regimen. The results of these studies were presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in February. | tradermichael | |
02/6/2017 10:33 | Toffeeman I would defo short around these levels. Very sensible. | lodgeview | |
02/6/2017 10:09 | Hi TM I am long GSK from 14.05 but 17.00ish seems to be resistance and so I will make a few pennies if it falls back. Seems to me that hedging is the best use of spread-betting. | toffeeman | |
02/6/2017 09:21 | Yes, I shouldn't think this rise will continue unbroken, and there may be a case for selling and returning after a market fall. There's a lot of politics going on at present that could cause a general correction ...... ;0) | tradermichael | |
02/6/2017 09:12 | Took a very small short at 17.15 (well I said I would, so I thought I should!) | toffeeman | |
02/6/2017 09:00 | Yep, seems like it. 🙄🙄 ShoreCap reiterating HOLD this morning | philanderer | |
02/6/2017 08:19 | I though Italy was on permanent holiday.. Onwards we go to 1900p | ny boy | |
02/6/2017 08:13 | Yes, he speaks a lot of sense. Good start this morning for the pharmas. Another public holiday here in Italy today for 'Republic Day' 😀👍 | philanderer | |
01/6/2017 22:04 | grahamite2 FYI David Buick - I first new him as a money broker, however his background was previously that of a discount house bill trader. He has latterly become the "voice" of the City working for Panmure Gordon. Must say I have always had time for both him and his viewpoint hxxps://davidbuik.wo | ianood | |
01/6/2017 12:59 | Beaufort Secs reiterating BUY increasing target from 1750p to 2000p | philanderer | |
01/6/2017 12:00 | Presumably Buik is an Oxford man. But leaving that little jibe aside, what he says is right in every particular. | grahamite2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions